查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1980694

全球心臟定位市场规模、份额、趋势和成长分析报告（2026-2034）

Global Cardiac Mapping Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计心臟定位市场将从 2025 年的 39.8 亿美元成长到 2034 年的 68.6 亿美元，2026 年至 2034 年的复合年增长率为 6.22%。

由于心血管疾病发病率的上升以及对先进诊断技术需求的增长，全球心臟定位市场正在快速成长。心臟定位系统能够帮助医师分析心臟的电活动，进而诊断及治疗心律不整及其他心臟疾病。这些系统广泛应用于电生理检查和微创心臟治疗。

心臟影像技术的进步、导管介入手术的日益普及以及医疗保健投资的增加，是推动市场成长的主要因素。医院和专科心臟中心正越来越多地采用先进的标测系统，以提高诊断准确性和治疗效果。此外，人口老化也促使人们对心臟护理技术的需求不断增长。

展望未来，随着医学影像、数据分析和数位医疗解决方案的不断创新，心臟定位市场预计将持续扩张。更精准、微创的心臟诊断工具的研发将进一步提升治疗效率。随着医疗机构日益重视心臟疾病的管理，对心臟定位技术的需求预计将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球心臟定位市场：依产品类型划分

  • 市场分析、洞察与预测
  • 非接触式心臟定位系统
  • 接触式心臟定位系统

第五章：全球心臟定位市场：依适应症划分

  • 市场分析、洞察与预测
  • 心房颤动
  • 心房扑动
  • 房室结折返性心搏过速（AVNRT）

第六章：全球心臟定位市场：依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 专科诊所
  • 心臟中心

第七章 全球心臟定位市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Abbott Laboratories
    • Acutus Medical Inc
    • Koninklijke Philips NV
    • Johnson & Johnson Services Inc
    • Boston Scientific Corporation
    • Lepu Medical Technology（Beijing）Co. Ltd
    • Medtronic
    • MicroPort Scientific Corporation
    • APN Health LLC
    • AngioDynamics
简介目录
Product Code: VMR112114930

The Cardiac Mapping Market size is expected to reach USD 6.86 Billion in 2034 from USD 3.98 Billion (2025) growing at a CAGR of 6.22% during 2026-2034.

The Global Cardiac Mapping Market is growing rapidly due to the increasing prevalence of cardiovascular diseases and the rising demand for advanced diagnostic technologies. Cardiac mapping systems help physicians analyze the electrical activity of the heart to diagnose and treat arrhythmias and other heart conditions. These systems are widely used during electrophysiology procedures and minimally invasive cardiac treatments.

Market growth is driven by technological advancements in cardiac imaging, increasing adoption of catheter-based procedures, and rising healthcare investments. Hospitals and specialized cardiac centers are increasingly using advanced mapping systems to improve diagnostic accuracy and treatment outcomes. Additionally, the growing aging population is contributing to the increasing demand for cardiac care technologies.

Looking ahead, the cardiac mapping market is expected to expand with ongoing innovations in medical imaging, data analysis, and digital healthcare solutions. The development of more precise and minimally invasive cardiac diagnostic tools will further enhance treatment efficiency. As healthcare providers focus on improving cardiovascular disease management, the demand for cardiac mapping technologies will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Non-contact Cardiac Mapping Systems
  • Contact Cardiac Mapping Systems

By Disease Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)

By End-user

  • Hospitals
  • Specialty Clinics
  • Cardiac Centers

COMPANIES PROFILED

  • Abbott Laboratories, Acutus Medical Inc, Koninklijke Philips NV, Johnson Johnson Services Inc, Boston Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Medtronic, MicroPort Scientific Corporation, APN Health LLC, AngioDynamics
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC MAPPING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Non-contact Cardiac Mapping Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Contact Cardiac Mapping Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC MAPPING MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Disease Indication
  • 5.2. Atrial Fibrillation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Atrial Flutter Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Atrioventricular Nodal Re-Entry Tachycardia (AVNRT) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC MAPPING MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC MAPPING MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Disease Indication
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Disease Indication
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Disease Indication
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Disease Indication
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Disease Indication
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC MAPPING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Acutus Medical Inc
    • 9.2.3 Koninklijke Philips N.V
    • 9.2.4 Johnson & Johnson Services Inc
    • 9.2.5 Boston Scientific Corporation
    • 9.2.6 Lepu Medical Technology (Beijing) Co. Ltd
    • 9.2.7 Medtronic
    • 9.2.8 MicroPort Scientific Corporation
    • 9.2.9 APN Health LLC
    • 9.2.10 AngioDynamics